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Abstract The kinase activity of c-src increased and peaked at
15 min after an application of uni-axial cyclic stretch in
HUVECs followed by a translocation of c-src to Triton-insoluble
fraction. Suppression of c-src by an antisense S-oligodeoxynu-
cleotide inhibited the stretch-induced tyrosine phosphorylation
and morphological changes. The stretch-induced increase in c-src
activity was inhibited by FK506, a specific inhibitor for
calcineurin, by Gd3+, a blocker for stretch activated channels,
and by the extracellular Ca2+ depletion suggesting the involve-
ment of SA channels. These results strongly suggest c-src plays
an important role in the downstream of SA channel activation
followed by the morphological changes.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Vascular endothelial cells composing the inner lining of
blood vessels show a spindle-like shape and align their longi-
tude along the vessel, whereas cells in culture show a polyg-
onal shape with random orientation. These morphological
features in situ are considered to be created by physical forces
from blood, such as the hydrodynamic shear stress from
blood £ow [1] and the periodic stretch due to wall distention
[2]. Particularly, the e¡ects of pulsative stretch have been ex-
tensively investigated using a variety of in-vitro simulation
systems [3^8]; however, the intracellular signaling mechanism
regulating the stretch-dependent morphological changes has
not been well elucidated.
Previous studies indicated that tyrosine phosphorylation of
focal proteins are critical for the stretch-induced morpholog-
ical changes [7,9]. Treatment with tyrosine kinase inhibitors,
such as genistein and herbimycin A, blocked the stretch-in-
duced morphological changes. Moreover, treatment with anti-
sense S-oligodeoxynucleotide (S-ODN) against pp125FAK also
suppressed the morphological changes [7]. However, few stud-
ies have been directed at verifying protein tyrosine kinases and
their coupling with mechanoreceptor signaling.
As a possible candidate for the mechanotransducer in HU-
VECs, we have been nominating a Ca2-permeable SA chan-
nel [6,7,10]. Existence of an SA channel has been demon-
strated in vascular endothelial cells by patch clamp
technique [10,11]. In addition, our previous studies indicated
that stretching endothelial cells increased intracellular Ca2
concentration via SA channel activation [10] and that Ca2
in£ux via SA channels was critical for the stretch-induced
morphological changes [6].
Several lines of evidence implicated that Ca2-dependent
tyrosine phosphorylation pathway is playing an important
role in intracellular signal transduction [12,13]. In cultured
epidermal keratinocytes, a rapid Ca2 mobilization was pro-
posed to stimulate the phosphatase activity of calcineurin re-
sulting in c-src activation [12]. In human platelets, addition of
EDTA to chelate extracellular Ca2 reduced the protein tyro-
sine phosphorylation induced by thrombin, suggesting that
platelet tyrosine kinase activity is controlled by extracellular
Ca2 [13].
Thus, these data led us to further investigate whether c-src
is activated upon cyclic stretch and whether Ca2 in£ux
through SA channel is critical for the activation of tyrosine
kinase, c-src, followed by tyrosine phosphorylation of focal
proteins and stretch-induced morphological changes.
In the present study, we demonstrated that cyclic stretch to
cultured endothelial cells activates c-src via SA channel acti-
vation followed by phosphorylation of focal proteins, result-
ing in morphological changes.
2. Materials and methods
2.1. Cell culture
Endothelial cells were prepared from human umbilical cord vein as
described previously [14]. In brief, human umbilical cord was asepti-
cally removed from placenta just after birth. The vein was washed
with phosphate bu¡ered saline (PBS, 137 mM NaCl, 8.10 mM
Na2HPO4, 2.68 mM KCl, 1.47 mM KH2PO4, pH 7.40), followed
by treatment with 0.2% trypsin for 10 min. The perfusate was centri-
fuged at 1500 rpm for 10 min. The resulting cells were washed with
PBS again, then plated in 35-mm dishes and maintained in EGM-
UV2 (Kurabo, Osaka, Japan). The cells used were within 2^4 pas-
sages.
ECV304 (JCRB 0744, Japan Health Science Research Resources
Bank) is an immortalized HUVEC, established by Takahashi et al.
[15], which has similar characteristics to HUVEC [16]. ECV304 were
maintained in DMEM supplemented with 10% fetal calf serum and
100 units/ml penicillin G sodium, 100 Wg/ml streptomycin sulfate and
250 Wg/mg amphotericin B. Cells were incubated in a tissue culture
incubator at 37‡C in a humidi¢ed atmosphere of 5% CO2 and 95%
air.
2.2. Stretch apparatus
The cells were stretched as previously described [5^8]. Brie£y, cells
were removed from the dish with 0.01% EDTA/0.02% trypsin and
transferred onto a silicone chamber coated with 50 Wg/ml ¢bronectin.
One end of the chamber is ¢rmly attached to a ¢xed frame, while the
other end is held on a movable frame. The movable frame is con-
nected to a motor driven shaft. The amplitude and the frequency of
stretch were controlled by a programmable microcomputer. The sili-
cone membrane was uniformly stretched over the whole membrane
area and lateral thinning did not exceed 1% at 20% stretch.
2.3. Immunoblotting
After the application of cyclic stretch, the cells were washed with
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ice-cold PBS containing 0.5 mM Na3VO4 and were lysed with a sam-
ple bu¡er 2U (62 mM Tris, pH 6.8, 2% SDS, 1% 2-mercaptoethanol,
0.003% bromophenol blue, 5% glycerol). Total cell lysate from equiv-
alent cell numbers were separated by 12.5% SDS-PAGE. The proteins
were transferred electrophoretically onto polyvinylidene £uoride
(PVDF) membrane (Immobile P, Millipore Crop, Bedford, MA,
USA). The membranes were blocked with 3% ovalbumin in PBS,
the membranes were subsequently probed with monoclonal antibodies
in PBS containing 3% ovalbumin for 1 h. The antibody-antigen com-
plexes were detected by using horseradish peroxidase-conjugated goat
anti-rabbit IgG (1:1000 dilution). Immunoreactivity was determined
using the ECL chemiluminescence reaction (Amersham, Arlington
Heights, IL, USA), according to the instructions provided by the
manufacturer and was measured using densitometry.
2.4. Immunoprecipitation and in vitro kinase assay
For immunoprecipitation, the cells were washed with ice-cold PBS
and were lysed by bu¡er A (10 mM Tris-HCl, 150 mM NaCl, 5 mM
EDTA, 1% Triton X-100, 1% DOC, 1% SDS, pH 7.40). Cell lysates
were centrifuged at 16 000Ug for 20 min at 4‡C twice and 50 Wl of
protein A-Sepharose-anti-mouse IgG were added to pre-clear the ly-
sate. One Wl of monoclonal anti-c-src were added and the samples
were incubated at 4‡C for 1 h. Then 30 Wl of protein A-Sepharose-
anti-mouse IgG were added, and samples were incubated at 4‡C for
1 h with gentle agitation. The resulting immunoprecipitates were
washed ¢ve times with bu¡er, A and three times with kinase bu¡er
(10 mM Tris-HCl, pH 7.40, 5 mM MnCl2). The kinase reaction was
started with the addition of 5 WCi of [32P]ATP, 1 Wl ATP, and acid-
treated enolase. The reaction was terminated after 10 min with the
addition of an equal volume of 2U SDS-sample bu¡er and the sam-
ples were boiled for 5 min. The samples were separated on 12.5%
SDS-PAGE and the autoradiogram was analyzed by BAS1500 radio-
activity imaging system (Fuji Photo Film, Tokyo, Japan).
2.5. Anti-sense S-oligodeoxynucleotide treatment
The anti-sense sequence against human c-src (accession number
X59932; 5P-GTC GGG GGC TGC TGT CTT-3P) and the sense se-
quence (3P-CAG CCC CCG ACG ACA GAA-5P) were designed using
the Genetyx (Softwear Development, Tokyo, Japan) so that they were
not engaged in snapback structures and not potentially exposed to the
stem structure of the mRNA. The designed sequences have relatively
low homology to any cDNA sequences found in EMBL and GenBank
databases. The S-ODNs were synthesized by RIKAKEN, Nagoya,
Japan. The cells were removed with 0.01% EDTA, 0.02% trypsin
and were suspended at a density of 1U106 cells/ml in PBS. 100 ng
of S-ODN was added to 400 Wl of cell suspension and the suspension
was transferred to an electroporation chamber, and were square-elec-
troporated at 75 V, 40 ms, 1 pulse using Electro Square Porator-T820
(BTX, San Diego, CA, USA). The e⁄ciency was greatest when cell
viability was 70%. Then the S-ODN treated cells were transferred
onto a 4-cm2 silicone chamber, incubated for 24 h.
2.6. Reagents
Mouse anti-c-src monoclonal antibody was purchased from Upstate
Biotechnology (Lake Placid, NY, USA). Rabbit anti-mouse IgG and
goat anti-rabbit IgG were obtained from Sigma (St. Louis, MO,
USA). Herbimycin A and genistein were purchased from Wako (To-
kyo, Japan). Gadolinium(III) chloride hexahydrate was purchased
from Aldrich (Milwaukee, MI, USA). Human plasma ¢bronectin
was puri¢ed according to Regnault et al. [17]. FK506 was a kind
gift from Fujisawa Pharmaceutical [18]. Other chemicals used were
of special grade.
3. Results
3.1. Cyclic stretch activated c-src
As we demonstrated that cyclic stretch-induced tyrosine
phosphorylation of focal proteins of HUVECs, we investi-
gated cyclic stretch-induce c-src kinase activation using an
in vitro kinase assay. After being subjected to 15^60 min of
cyclic stretch (20%, 1 Hz), the cells were lysed and were im-
munoprecipitated with anti-c-src antibody. The immunopreci-
pitates were subjected to an in vitro kinase assay using enolase
as a substrate followed by SDS-PAGE and autoradiography.
The autoradiogram of phosphorylated enolase at 40 kDa
shows an increase in kinase activity of c-src (Fig. 1A, upper
panel). Immunoblot probed with anti-src monoclonal anti-
body (Fig. 1A, lower panel) shows that an equal amount of
the protein was loaded in each lane. The activity of c-src
peaked at 15 min (3.2-fold increase, n = 5) and decreased grad-
ually (Fig. 1B). The autophosphorylation of c-src of HUVECs
was so faint that we could not detect a band at 60 kDa
corresponding to c-src. In the immortalized HUVEC cell
line (ECV304 cells), cyclic stretch also induced c-src kinase
activation, which were detected as autophosphorylation and
enolase phosphorylation (data not shown).
3.2. Cyclic stretch induced translocation of c-src
As c-src requires membrane localization for their normal
function in intracellular signaling, the subcellular distribution
of c-src was determined by immunoblotting using anti-c-src
antibody. The amount of c-src in the cytoskeletal fraction
gradually increased in the course of stretch (Fig. 2A). Local-
ization of c-src in HUVECs was identi¢ed by immunostain-
ing. In control static cells, no particular structure could be
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Fig. 1. Stretch-induced kinase activation of c-src. A: Upper panel:
Autoradiogram of in vitro kinase assay of c-src using acid-treated
enolase as a substrate. The phosphorylation of enolase increased
and peaked at 15 min. The autophosphorylation of c-src could not
be observed in HUVECs at 60 kDa. The autoradiogram is represen-
tative of 4 experiments. Lower panel: Immunoblot probed with
anti-src monoclonal antibody shows that an equal amount of the
protein was loaded in each lane. B: Time course of the kinase acti-
vation of c-src in response to cyclic stretch. Asterisks denote those
values that are signi¢cantly di¡erent (P6 0.01) from control
(0 min).
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observed (Fig. 2B, left), whereas in stretched cells (20 min) the
cells aligned perpendicular to the stretch direction and the
staining could be observed as patches along cytoskeletal struc-
tures (Fig. 2B, right).
3.3. Antisense c-src suppressed stretch-induced tyrosine
phosphorylation
To con¢rm that the activated c-src really tyrosine-phos-
phorylate cellular proteins, we employed antisense S-oligo-
deoxynucleotides (ODNs) against c-src to reduce speci¢cally
the expression of c-src. Synthesized antisense S-ODNs against
c-src including the ¢rst Met (atg) was electroporated into
HUVECs and the cells were cultured for 24 h. The sense S-
ODN against c-src was used as a control. Immunoblot using
anti-c-src monoclonal antibody revealed that in the antisense
S-ODN treated cells the amount of c-src was decreased within
24 h, whereas in the sense S-ODN treated cells, the amount of
c-src was unchanged (Fig. 3A, upper panel). The e¡ect of
antisense S-ODN was dose- and time-dependent. For further
experiments, the cells were electroporated at the concentration
of 20 WM S-ODN and were cultured for 24 h before being
subjected to stretch. As an internal control, the amount of
actin was accessed by immunoblot with anti-actin monoclonal
antibody (Fig. 3A, lower panel). The amount of actin was not
signi¢cantly changed with the S-ODN treatment. In the sense
S-ODN treated cells, the level of tyrosine phosphorylation
increased in response to cyclic stretch as previously reported,
whereas in the antisense S-ODN treated cells the level of
tyrosine phosphorylation slightly increased but the increase
was much less as compared with the sense S-ODN treated
cells (Fig. 3B, upper panel). The e¡ects of the ODNs on the
morphological changes of HUVECs in response to mechanical
stretch were examined. In the sense S-ODN treated cells, mor-
phological changes of the cells were very similar to those in
control cells. In the cells treated with the antisense S-ODN,
the cells had almost no morphological changes. These results
clearly indicate that c-src may play an important role in
stretch-induced morphological changes.
3.4. Activation of c-src was regulated by the SA channel
It is of interest to investigate the mechanism(s) by which c-
src is activated under cyclic stretch, as previous studies from
our laboratory [6,10] and others [19] demonstrated that me-
chanical stretch activated Ca2-permeable SA channels lead-
ing to an increase in intracellular Ca2 concentration ([Ca2]i)
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Fig. 2. A: Translocation of c-src to the cytoskeletal fraction in re-
sponse to cyclic stretch. After the application of cyclic stretch (1
Hz, 20% in length) for 20 min, the cytoskeletal fraction was immu-
noblotted with anti-src monoclonal antibody. The amount of c-src
in the cytoskeletal fraction increased after the application of stretch.
The immunoblot is a representative of 5 experiments. B: Immunos-
taining study of c-src in response to cyclic stretch. In control static
cells, no particular structure could be observed (left). After the ap-
plication of cyclic stretch (1 Hz, 20% in length) for 20 min, the cells
aligned perpendicularly to the stretch direction and the staining
could be observed as patches along the cytoskeletal structures
(right). The bar at the bottom indicates 10 Wm. A double-headed ar-
row indicates the direction of the stretch axis.
Fig. 3. E¡ect of the antisense S-ODN against c-src. A: Upper pan-
el : The treatment of HUVEC with the antisense S-ODN against c-
src for 24 h depleted the amount of c-src protein, whereas that with
the sense S-ODN did not. Lower panel: S-ODN treatment had no
e¡ect in the expression of actin as an internal control. B: Upper
panel: The level of tyrosine phosphorylation increased in time de-
pendent manner in response to cyclic stretch in the sense S-ODN
treated cells, whereas the level of tyrosine phosphorylation was
much lower in the antisense S-ODN treated cells. Lower panel: Im-
munoblot probed with anti-src monoclonal antibody shows that an
equal amout of the protein was loaded in each lane. The immuno-
blot is representative of 5 experiments.
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and that the SA channel-dependent [Ca2]i increase was in-
dispensable for the stretch-induced morphological changes in
endothelial cells. In view of the involvement of Ca2 through
the SA channel in the stretch-dependent morphogenesis in
HUVECs, we examined the e¡ects of Gd3, SA channel
blocker [20], extracellular Ca2 chelation (EGTA), and intra-
cellular Ca2 chelation (BAPTA/AM) on the kinase activity
of c-src. The application of Gd3 (10^50 WM) inhibited the
increase in the c-src kinase activity dose-dependently and the
removal of extracellular Ca2 by EGTA or intracellular Ca2
by 5 WM BAPTA/AM also inhibited the kinase activity (Fig.
4A). These results strongly suggest that Ca2 in£ux through
SA channels is critical for the activation of c-src.
3.5. Involvement of Ca2+-dependent phosphatase in the
activation of c-src
It is well known that the dephosphorylation of tyrosine-
phosphorylated Tyr(P)-527 is essential for the activation of
c-src [21]. Several papers reported that this is due to an acti-
vation of intracellular PTPases, including Ca2-dependent
phosphatase. Thus, we investigated the involvement of calci-
neurin, Ca2/calmodulin-dependent protein phosphatase
(PPIIB), in this system. FK506, one of the immunosuppres-
sants, is known to inhibit calcineurin speci¢cally [22]. In the
presence of FK506, the increase in kinase activity of c-src
induced by stretch was almost completely inhibited at 50
WM and partially inhibited at 20 WM (Fig. 4B). The morpho-
logical change induced by stretch was also inhibited by treat-
ment with FK506 (data not shown).
4. Discussion
In the present study, we ¢rst demonstrated that unidirec-
tional cyclic stretch induced the activation and translocation
of c-src in HUVECs. Furthermore, the activation of c-src
kinase is indispensable for the stretch-induced morphological
change, such as alignment and elongation perpendicular to the
stretch axis.
Several lines of evidence suggest that these stretch-induced
morphological changes contain complex signaling mecha-
nisms. First, the morphological change process involves pro-
tein tyrosine phosphorylation of focal adhesion proteins.
Stretching the cells increased the phosphotyrosine contents
in the focal proteins, and tyrosine kinase inhibitors such as
herbimycin A and genistein blocked the stretch-induced mor-
phological changes [7]. Second, suppression of pp125FAK by
an antisense S-ODN blocked the morphological changes [7].
Third, the morphological changes are likely to be triggered by
SA channels. Depletion of extracellular Ca2 and an applica-
tion of Gd3, an inhibitor of SA channel, inhibited the mor-
phological changes, thus the Ca2 in£ux through SA channels
is critical for the morphological changes [6]. These observa-
tions led us to further investigate which tyrosine kinase(s) are
responsible for the stretch-induced protein tyrosine phosphor-
ylation and morphological changes. Among the tyrosine kin-
ases, we ¢rst examined the activation of c-src because
pp125FAK is known to be a good substrate of c-src and a
recent study reported the activation of c-src kinase in lung
cells to strain [23]. As shown in Fig. 1, cyclic stretch induced
rapid increase in kinase activity, which may be regulated by
intracellular Ca2. Other members of the src kinase family
(fyn, lyn) were examined, however, we could not detect any
changes in their kinase activity (data not shown).
Activation of c-src is induced by the dephosphorylation of
tyrosine-phosphorylated Tyr(P)-527 [21]. Although the regu-
lation mechanism of the kinase activity is still under investi-
gation, it is reported that c-src kinase (CSK) constitutively
phosphorylates Tyr(P)-527 of c-src to inactivate the c-src kin-
ase activity and that the dephosphorylation of Tyr(P)-527 by
phosphatase increases the activity [24]. In our study, a Ca2-
dependent phosphatase is one of the favorable candidates
since the stretch-dependent protein tyrosine phosphorylation
was demonstrated to be [Ca2]i-dependent [11]. Calcineurin, a
Ca2/calmodulin-dependent protein phosphatase (PP2B) be-
longs to the family of Ser/Thr speci¢c enzymes [25] but is
also active on phosphotyrosine residues [26]. Thus, it is pos-
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Fig. 4. A: The involvement of SA channel in the regulation of c-src
kinase activity. HUVEC was cyclically stretched for 30 min in the
absence of extracellular Ca2 or after addition of 10 WM Gd3. The
kinase activity of c-src increased in normal control, whereas it was
inhibited by the removal of extracellular Ca2 or by the addition of
10 WM Gd3. B: The e¡ects of FK506 on the stretch induced acti-
vation of c-src. HUVEC was cyclically stretched for 30 min in the
presence or absence of FK506. The cell lysate was subjected to the
in vitro kinase assay. The increase in the kinase activity of c-src by
cyclic stretch was inhibited in dose-dependent manner (20, 50 WM).
Asterisks denote those values are signi¢cantly di¡erent (P6 0.01)
from control values.
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sible to think that changes in [Ca2]i regulate the kinase ac-
tivity through calcineurin activation. To con¢rm this, we em-
ployed FK506, a speci¢c inhibitor of calcineurin. FK506 is
reported to bind FK506 binding protein (FKBP) and the
complex inhibits the activity of calcineurin [22]. Actually, we
con¢rmed the existence of FKBP and calcineurin in HUVECs
by immunoblotting experiments (data not shown). In our data
(Fig. 4B), inhibition of the Ca2 in£ux or the application of
FK506 suppressed c-src kinase activity.
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